Site-Level Strategies to Drive Better Clinical Research Outcomes in Type 2 Diabetes Trials
Conducting clinical trials in Type 2 Diabetes (T2D) presents a unique set of challenges at the site level. Sites are […]
Conducting clinical trials in Type 2 Diabetes (T2D) presents a unique set of challenges at the site level. Sites are […]
As the vaccine industry advances, recruiting participants for clinical trials becomes more complex. Clinical development professionals face challenges such as
High screen failure rates in central nervous system (CNS), neurological, and psychiatric clinical trials are among the most significant barriers
Background The U.S. Food and Drug Administration (FDA) is actively seeking diversity in clinical trials. While Caucasians represent 58% of
4 Minute Read Clinical trials—and the sites where these studies are conducted—exist to prove the safety and efficacy of therapies
5 Minute Read Clinical trial diversity is essential to ensure novel therapeutics are effective and safe for the populations they
5 Minute Read Obesity is a growing global health issue, with its prevalence reaching epidemic proportions. Affecting more than one